Long-Term Outcomes After Autologous or Tissue Expander/Implant-Based Breast Reconstruction and Postmastectomy Radiation for Breast Cancer.


Journal

Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 11 03 2019
revised: 07 06 2019
accepted: 11 06 2019
pubmed: 27 6 2019
medline: 27 3 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

The toxicity profile of breast reconstruction with postmastectomy radiation therapy (PMRT) varies by technique and timing, and long-term data are limited. We compared rates of complications requiring reoperation (CRR) and reconstruction failure (RF) between immediate autologous reconstruction (I-AR), immediate tissue expander/implant reconstruction (I-TE/I), delayed autologous reconstruction (D-AR), and delayed tissue expander/implant reconstruction (D-TE/I) in patients receiving PMRT. Patients who received autologous reconstruction (AR) or tissue expander/implant reconstruction (TE/I) and PMRT between 2000 to 2008 were included. Reconstruction was immediate if performed on the same day as mastectomy followed by PMRT (I-AR or I-TE/I) or delayed if after PMRT (D-AR and D-TE/I). CRR was defined as an unplanned return to the operating room for infection, dehiscence, necrosis, hematoma, or hernia (with AR) and extrusion, leak, or contracture (with TE/I). RF was defined as unplanned conversion to another reconstruction technique or to flat chest wall. Cumulative incidence of CRR and RF was calculated using Kaplan-Meier and compared using the log-rank test. Logistic regression was used to identify variables associated with CRR and RF. Two hundred four patients were included. Median follow-up was 8 years. There were 127 AR cases (63%) and 77 TE/I cases (38%). At 5 years, CRR was 18%, 38%, 34%, and 70% (P = .010) and RF was 4%, 22%, 7%, and 56% (P < .0001) for I-AR, I-TE/I, D-AR, and D-TE/I, respectively. On multivariate analysis, TE/I (hazard ratio [HR] 2.0; P = .011), body mass index ≥30 (HR 3.9; P = .002), and smoking (HR 2.7; P = .001) were significant predictors for CRR, and TE/I (HR 6.6; P < .0001), diabetes (HR 4.1; P = .044), and hypertension (HR 3.5; P = .005) were significant for RF. When excluding RF because of infection, the rate of RF was not significantly different among the 4 groups (P = .23). With PMRT, TE/I reconstruction in the immediate and delayed setting is associated with higher CRR and RF compared with AR. Patient factors should guide selection of technique. Efforts to reduce rates of RF with TE/I should focus on minimizing risks for infection.

Identifiants

pubmed: 31238166
pii: S1879-8500(19)30179-1
doi: 10.1016/j.prro.2019.06.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e497-e505

Informations de copyright

Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Auteurs

Bindu V Manyam (BV)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Chirag Shah (C)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address: shahc4@ccf.org.

Neil M Woody (NM)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Chandana A Reddy (CA)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Michael A Weller (MA)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Aditya Juloori (A)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Mihir Naik (M)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Stephanie Valente (S)

Breast Services, Department of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Stephen Grobmyer (S)

Breast Services, Department of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Paul Durand (P)

Dermatology and Plastic Surgery Institute, Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Risal Djohan (R)

Dermatology and Plastic Surgery Institute, Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Rahul D Tendulkar (RD)

Taussig Cancer Institute, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH